Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CHEK1 |
Variant | T226Nfs*19 |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | CHEK1 T226Nfs*19 indicates a shift in the reading frame starting at amino acid 226 and terminating 19 residues downstream causing a premature truncation of the 476 amino acid Chek1 protein (UniProt.org). T226Nfs*19 has been identified in sequencing studies (PMID: 36866757), but has not been biochemically characterized and therefore, its effect on Chek1 protein function is unknown (PubMed, Nov 2024). |
Associated Drug Resistance | |
Category Variants Paths |
CHEK1 mutant CHEK1 T226Nfs*19 |
Transcript | NM_001114121.2 |
gDNA | chr11:g.125635491dupA |
cDNA | c.676dupA |
Protein | p.T226Nfs*19 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001114122 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001114121.2 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001244846 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001274.5 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
XM_024448337.2 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001114122.2 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001244846.1 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001114121 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
XM_047426311.1 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001114122.3 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001244846.1 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001274.5 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
XM_017017146 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
XM_024448337.1 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001114121.2 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
NM_001274 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
XM_017017146.2 | chr11:g.125635491dupA | c.676dupA | p.T226Nfs*19 | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|